Rapid HPLC determination of venlafaxine in microbial biotransformation studies

Current Trends in Biotechnology and Pharmacy

Volumn 3, Issue 1, 2009, Pages 64-70

  Vidyavathi, M ^a   Krishna, D R ^b   Prasad, K V S R G ^a   Vidyasagar, J ^b  

^a INSTITUTE OF PHARMACEUTICAL TECHNOLOGY   (India)

^b KAKATIYA UNIVERSITY   (India)

Author keywords

Microbial biotransformation; Venlafaxine; Venlafaxine HPLC

Indexed keywords

DRUG METABOLITE; VENLAFAXINE;

ACCURACY; BIOTRANSFORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG DETERMINATION; DRUG METABOLISM; DRUG TRANSFORMATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; QUALITY CONTROL; REVIEW; SACCHAROMYCES CEREVISIAE;

SACCHAROMYCES;

EID: 62849119563     PISSN: 09738916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Matoga, M., Perhourcq, F., Titier, K., Dumora, F. and Jarry, C. (2001). Rapid high-performance liquid - chromatographic measurement of venlafaxine and Odesmethyl venlafaxine in human plasma. Application to management of acute intoxications. J. Chromatogr B Biomed. Sci. Appl., 760: 213-218.
2. Goeringer, K.E., McIntyre, I.K. and Dummer, O.H. (2001). Postmortem tissue concentrations of venlafaxine. Forensic Sci. Int., 121: 70-75.
3. Wellington K and Perry CM. (2001). Venlaflaxine extended - release: a review of its use in the management of major depression. CNS Drugs., 15: 643-669.
4. Taft, D.R., Iyer, G.R., Behr, L. and DiGregorio, R.V.S. (1997). Application of first - pass effect model to characterize the pharmacokinetic disposition of venlafaxine after oral administration to human subjects. Drug Metab. Dispos., 25(10): 1215-1218.
5. Clark, A.M., McChesney, J.D. and Hufford, C.D. (1985). The use of microorganisms for the study of drug metabolism. Med Res Rev., 5: 231-253.
6. Clark, A.M. and Hufford, C.D. (1991). Use of microorganisms for the study of drug metabolism: an update. Med. Res. Rev., 11(5): 473-501.
7. Beukers, R., Marx, A.F. and Zuidweg, M.H.J. (1972). Microbial conversion as a tool in the preparation of drugs. In. Drug design Ariens EJ, ed., vol. 3, New York: Academic Press.
8. Smith, R.V. and Rosazza, J.P. (1975). 9. Smith, R.V and Rosazza, J.P. (1983). Microbial models of mammalian metabolism. J. Nat. Prod., 46: 79-91.
9. Smith RV and Rosazza JP (1974); Microbial models of mammalian metabolism, aromatic hydroxylation. Asch Biochem Biophys., 161: 551-558.
10. Zhang D, Evans FE, Freeman JP, Duhart B and Cerniglia CE (1995). Biotransformation of amitryptilline by Cunninghamella elegans Drug Metab Dispos, 23:1417-1425.
11. Zhang, D., Evans, F.E., Freeman, J.P., Yang, Y., Deck, J. and Cerniglia, C.E. (1996). Formation of mammalian metabolites of cyclobenzaprine by the fungus Cunninghamella elegans. Chem Biol., 102: 79-92.
12. Moody, J.D., Freeman, J.P. and Cerniglia, C.E. (1999). Biotransformation of doxepin by Cunninghamella elegans. Drug Metab Dispos., 27: 1157-1164.
13. Moody, J.D., Freeman, J.P., Fu, P.P. and Cerniglia, C.E. (2002). Biotransformation of Mirtazapine by Cunninghamella elegans. Drug Metab Dispos., 30: 1274-1279.
14. Srisilam, K. and Veeresham, C. (2003). Biotransformation of drugs by microbial cultures for predicting mammalian drug metabolism. Biotechnol. Advance., 21: 3-39
15. Tournel, G., Houdret, N., Hedouin, V.D., Eveaux, M., Gosset, D. and Lhermitte, M. (2001). High-performance liquid chromatographic method to screen and quantitate seven selective serotinine reuptake inhibitors in human serum. J. Chromat B., 761: 147-158.
16. Wachgler, R., Moll, W., Konig, P. and Conca, A. (2004). Quantification of venlafaxine and O-demethylvenlafaxine in human serum using HPLC analysis. Int. J. Clin Pharmacol. Ther., 42: 724-728.